Trial site
Allied Biomedical Research Institute
- 9running trials
- 5closed trials
The trials here
What the 14 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease4 trials
- Lupus (SLE)4 trials
- Gout2 trials
- Chronic kidney disease1 trial
- High blood pressure1 trial
- Migraine1 trial
- Osteoarthritis1 trial
- Ulcerative colitis1 trial
- Phase
- Phase 313 trials
- Phase 21 trial
- Status
- Active, not recruiting6 trials
- Completed4 trials
- Recruiting2 trials
- Enrolling by invitation1 trial
- Terminated1 trial
- Lead sponsor
- Viatris Innovation GmbH4 trials
- Eli Lilly and Company2 trials
- LG Chem2 trials
- Cognition Therapeutics1 trial
- Grünenthal GmbH1 trial
- and 4 more
Running trials
Recruiting
Active, not recruiting
Enrolling by invitation
Long-term Safety and Tolerability of Cenerimod in Adults With Systemic Lupus Erythematosus
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Type
Active, not recruiting
A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine
Active, not recruiting
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lupus (SLE)2 recruiting
- Alzheimer disease1 recruiting
Closed trials
Completed
Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients
Completed
Tigulixostat, Phase 3 Study, Placebo Controlled in Gout Patients
Completed
Terminated
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026